HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multiple and incidentally found cancers detected by 18F-FDG positron emission tomography/CT at one examination.

Abstract
During the initial 8 months period of 18F-FDG PET/CT examination in our institution eleven cases of double cancers were detected. Eight cases were simultaneous second cancers and 3 cases are consecutive cancers. All cases are clinical ones and were referred from both outside hospitals and our own hospital. 18F-FDG PET/CT examination were utilized either to determine the extent of tumor or to stage the cancer or to detect recurrent tumors during the follow-up period. During the 8-months period 964 cases were studied. Therefore, the detection rates of simultaneous and consecutive cancers are 0.83% and 0.31% respectively. All together the detection rate of double cancer was 1.14%. To gain the general conception of double cancers the authors reviewed the autopsy registry of Japanese Society of Pathology during the four years from 2000 through 2003, and tabulated the combination of primary and second cancers. Frequently found combination of cancers were cancers of the thyroid, lung, stomach, liver, biliary tract, colon, rectum, and prostate. 18F-FDG PET/CT examination seems to be very useful in the management of cancer patients in terms of whole patient care.
AuthorsShoichi Takekawa, Yasunaga Kodaira, Maiko Baba, Yasuhiro Igarashi, Akiyoshi Konno, Yasushi Teranishi, Toshihiro Nakazawa, Hideo Sakuma, Kazuo Watanabe, Makoto Miyazaki, Fumio Shishido
JournalFukushima journal of medical science (Fukushima J Med Sci) Vol. 53 Issue 2 Pg. 109-18 (Dec 2007) ISSN: 0016-2590 [Print] Japan
PMID18402290 (Publication Type: Journal Article)
Chemical References
  • Fluorodeoxyglucose F18
Topics
  • Aged
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Male
  • Middle Aged
  • Neoplasms, Multiple Primary (diagnosis)
  • Neoplasms, Second Primary (diagnosis)
  • Positron-Emission Tomography (methods)
  • Tomography, X-Ray Computed (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: